$ETNB
89bio, Inc.

2019 Q4 Form 10-Q Financial Statement

#000156459020053677 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2019 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.420M $1.520M $830.0K
YoY Change 236.11% 204.0%
% of Gross Profit
Research & Development $7.190M $6.680M $3.165M
YoY Change 94.85% 103.1%
% of Gross Profit
Depreciation & Amortization $10.00K $0.00 $10.00K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $9.610M $8.198M $3.999M
YoY Change 117.91% 116.53%
Operating Profit -$9.611M -$8.198M $3.999M
YoY Change 118.04% 116.53% -157.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.540M -$10.47M $10.97M
YoY Change 4670.0% 2662.53%
Pretax Income -$19.15M -$18.67M -$14.97M
YoY Change 315.4% 348.21%
Income Tax $130.0K $57.00K $6.000K
% Of Pretax Income
Net Earnings -$19.28M -$18.73M -$14.97M
YoY Change 315.76% 349.58% 103.08%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.398M -$1.553M -$1.227M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.30M $16.20M $21.90M
YoY Change
Cash & Equivalents $93.34M $16.23M $21.92M
Short-Term Investments
Other Short-Term Assets $2.000M $400.0K $100.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $95.33M $16.59M $22.00M
YoY Change 742.4%
LONG-TERM ASSETS
Property, Plant & Equipment $155.0K $49.00K $0.00
YoY Change 369.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $72.00K $1.700M $300.0K
YoY Change
Total Long-Term Assets $227.0K $1.766M $300.0K
YoY Change 328.3%
TOTAL ASSETS
Total Short-Term Assets $95.33M $16.59M $22.00M
Total Long-Term Assets $227.0K $1.766M $300.0K
Total Assets $95.55M $18.35M $22.30M
YoY Change 740.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $989.0K $3.571M $1.000M
YoY Change -34.46%
Accrued Expenses $4.620M $2.992M $2.700M
YoY Change 293.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.600M $22.58M $9.500M
YoY Change 28.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.600M $22.58M $9.500M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $5.600M $22.60M $9.500M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$73.60M -$54.31M
YoY Change 354.97%
Common Stock $163.5M $342.0K
YoY Change 137328.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.94M -$53.97M -$35.36M
YoY Change
Total Liabilities & Shareholders Equity $95.55M $18.35M $22.30M
YoY Change 740.47%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$19.28M -$18.73M -$14.97M
YoY Change 315.76% 349.58% 103.08%
Depreciation, Depletion And Amortization $10.00K $0.00 $10.00K
YoY Change 0.0%
Cash From Operating Activities -$11.13M -$6.200M -$3.960M
YoY Change 238.3% 144.09% -40.36%
INVESTING ACTIVITIES
Capital Expenditures -$110.0K -$10.00K -$20.00K
YoY Change 0.0% -33.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$110.0K -$10.00K -$20.00K
YoY Change 0.0% -33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 88.37M 490.0K 18.84M
YoY Change 881.89% 27.56%
NET CHANGE
Cash From Operating Activities -11.13M -6.200M -3.960M
Cash From Investing Activities -110.0K -10.00K -20.00K
Cash From Financing Activities 88.37M 490.0K 18.84M
Net Change In Cash 77.13M -5.720M 14.86M
YoY Change 1250.79% 124.31% 83.46%
FREE CASH FLOW
Cash From Operating Activities -$11.13M -$6.200M -$3.960M
Capital Expenditures -$110.0K -$10.00K -$20.00K
Free Cash Flow -$11.02M -$6.190M -$3.940M
YoY Change 234.95% 144.66% -40.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73596000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
89944000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95553000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14606000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18725000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16884244
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
611226
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-10544000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
79902000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
75000
CY2020Q2 etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
634000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
910000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11771000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1154000
CY2020Q3 etnb Stock Issued During Period Issuance Costs
StockIssuedDuringPeriodIssuanceCosts
1208000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4439000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-20461000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14973000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-35358000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-53971000
us-gaap Profit Loss
ProfitLoss
-38137000
us-gaap Depreciation
Depreciation
12000
us-gaap Share Based Compensation
ShareBasedCompensation
223000
etnb Deferred Tax Assets
DeferredTaxAssets
69000
etnb Revaluation Of Convertible Preferred Stock Liability
RevaluationOfConvertiblePreferredStockLiability
21018000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-85000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
154000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
314000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1025000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77804000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
158287000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
20000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
161000
etnb Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
686000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25000
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
38000
etnb Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
634000
etnb Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
607000
etnb Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
942000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
135000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include but are not limited to the fair value of stock options, the convertible preferred stock liability and certain accruals. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates. </p>
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
112000
CY2019Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
48000
etnb Capital Contributions Related To Extinguishment Of Preferred Stock Liability
CapitalContributionsRelatedToExtinguishmentOfPreferredStockLiability
25600000
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201813Member
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2020-01-01
CY2020Q3 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
false
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
103643000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
208000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
108000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1154000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
609000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13403
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-06-28
etnb Reorganization Exchange Of Equity Percentage Of Common Stock Issued Upon Exchange
ReorganizationExchangeOfEquityPercentageOfCommonStockIssuedUponExchange
1.00
etnb Reorganization Exchange Of Equity Percentage Of Ordinary Shares Exchanged
ReorganizationExchangeOfEquityPercentageOfOrdinarySharesExchanged
1.00
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.160849
CY2020Q3 etnb Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
18338000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
121981000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2020Q3 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
2602000
CY2019Q4 etnb Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
2326000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1679000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1396000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
769000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
573000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
288000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
325000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
64000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
232000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
8000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
304000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2557000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1320243
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40482
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1875358
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
492557
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.34
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.68
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.87
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.08
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.24
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M25D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30353000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28652000
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11537000
CY2019Q4 etnb Capital Contribution Related To Extinguishment Of Preferred Stock Liability
CapitalContributionRelatedToExtinguishmentOfPreferredStockLiability
25600000

Files In Submission

Name View Source Status
0001564590-20-053677-index-headers.html Edgar Link pending
0001564590-20-053677-index.html Edgar Link pending
0001564590-20-053677.txt Edgar Link pending
0001564590-20-053677-xbrl.zip Edgar Link pending
etnb-10q_20200930.htm Edgar Link pending
etnb-20200930.xml Edgar Link completed
etnb-20200930.xsd Edgar Link pending
etnb-20200930_cal.xml Edgar Link unprocessable
etnb-20200930_def.xml Edgar Link unprocessable
etnb-20200930_lab.xml Edgar Link unprocessable
etnb-20200930_pre.xml Edgar Link unprocessable
etnb-ex101_102.htm Edgar Link pending
etnb-ex311_6.htm Edgar Link pending
etnb-ex312_7.htm Edgar Link pending
etnb-ex32_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gh0gykwszepk000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending